OncoSTING

Baltimore, United States

OncoSTING is developing novel bladder cancer therapies by harnessing the potency of standard BCG immunotherapy

$256K raised

Jun 2022

Grant

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has OncoSTING raised?

OncoSTING has raised $256K in total funding. The most recent round was Grant. The last funding was announced in June 2022.

Who are OncoSTING's investors?

OncoSTING's investors include National Science Foundation, Maryland Innovation Initiative (MII).

Where is OncoSTING headquartered?

OncoSTING is headquartered in Baltimore, United States.

What does OncoSTING do?

OncoSTING is developing novel bladder cancer therapies by harnessing the potency of standard BCG immunotherapy

What stage is OncoSTING at?

OncoSTING is at the Grant stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated June 1, 2022.

MLA

"OncoSTING — Funding & Investors." VCBacked, June 1, 2022, https://www.vcbacked.co/company/oncosting. Accessed July 3, 2026.

APA

VCBacked. (2022). OncoSTING — Funding & Investors. Retrieved July 3, 2026, from https://www.vcbacked.co/company/oncosting

Wikipedia (cite web)

{{cite web |title=OncoSTING — Funding & Investors |url=https://www.vcbacked.co/company/oncosting |website=VCBacked |access-date=July 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated June 1, 2022.